We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$2.5B
AUM Growth
+$144M
Cap. Flow
+$16.9M
Cap. Flow %
0.68%
Top 10 Hldgs %
23.95%
Holding
453
New
26
Increased
85
Reduced
124
Closed
20

Top Buys

1
LLY icon
Eli Lilly
LLY
+$23M
2
NVAX icon
Novavax
NVAX
+$18.4M
3
IQ icon
iQIYI
IQ
+$17.4M
4
CBOE icon
Cboe Global Markets
CBOE
+$17M
5
NFLX icon
Netflix
NFLX
+$16.8M

Top Sells

1
SRPT icon
Sarepta Therapeutics
SRPT
+$27.7M
2
ROKU icon
Roku
ROKU
+$20.6M
3
SPG icon
Simon Property Group
SPG
+$16.5M
4
NIO icon
NIO
NIO
+$15.7M
5
MRNA icon
Moderna
MRNA
+$13.5M

Sector Composition

1 Consumer Staples 21.66%
2 Healthcare 21%
3 Consumer Discretionary 11.38%
4 Communication Services 9.41%
5 Materials 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVB icon
276
AvalonBay Communities
AVB
$27.3B
$86K ﹤0.01%
412
– –
CSCO icon
277
Cisco
CSCO
$444B
$86K ﹤0.01%
1,619
-745
-32% -$39.2K
GNRC icon
278
Generac Holdings
GNRC
$12.7B
$86K ﹤0.01%
206
– –
LEN icon
279
Lennar Class A
LEN
$20.2B
$85K ﹤0.01%
880
– –
OKE icon
280
Oneok
OKE
$58.7B
$84K ﹤0.01%
1,508
– –
PNC icon
281
PNC Financial Services
PNC
$101B
$83K ﹤0.01%
435
+304
+232% +$57.1K
IP icon
282
International Paper
IP
$19.7B
$82K ﹤0.01%
1,416
– –
CERN
283
DELISTED
Cerner Corp
CERN
$82K ﹤0.01%
1,044
– –
ALB icon
284
Albemarle
ALB
$14.2B
$80K ﹤0.01%
476
– –
DRI icon
285
Darden Restaurants
DRI
$22.7B
$79K ﹤0.01%
542
– –
XLNX
286
DELISTED
Xilinx Inc
XLNX
$79K ﹤0.01%
543
-293
-35% -$37.2K
EIX icon
287
Edison International
EIX
$29.8B
$78K ﹤0.01%
1,350
– –
NTRS icon
288
Northern Trust
NTRS
$34B
$78K ﹤0.01%
678
– –
APD icon
289
Air Products & Chemicals
APD
$66B
$77K ﹤0.01%
269
+132
+96% +$38.7K
AXP icon
290
American Express
AXP
$242B
$77K ﹤0.01%
468
– –
BF.B icon
291
Brown-Forman Class B
BF.B
$11.8B
$77K ﹤0.01%
1,034
– –
VTR icon
292
Ventas
VTR
$46.5B
$76K ﹤0.01%
1,333
– –
TAP icon
293
Molson Coors Class B
TAP
$7.7B
$75K ﹤0.01%
1,388
– –
VRSK icon
294
Verisk Analytics
VRSK
$26.2B
$75K ﹤0.01%
+430
New +$76.3K
DKNG icon
295
DraftKings
DKNG
$12.3B
$74K ﹤0.01%
1,410
– –
IT icon
296
Gartner
IT
$9.43B
$74K ﹤0.01%
306
– –
MKC icon
297
McCormick & Company Non-Voting
MKC
$13.9B
$74K ﹤0.01%
840
– –
MLM icon
298
Martin Marietta Materials
MLM
$33.9B
$74K ﹤0.01%
211
– –
TSCO icon
299
Tractor Supply
TSCO
$15.9B
$74K ﹤0.01%
1,980
– –
ULTA icon
300
Ulta Beauty
ULTA
$20.7B
$74K ﹤0.01%
214
-598
-74% -$196K
10 11
12
13 14

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q2 2021 Portfolio in Review

As of Q2 2021, TOBAM held 453 positions worth $2.5B, up 6.1% from $2.35B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

TOBAM's Q2 2021 filing shows 26 new, 85 increased, 124 reduced and 20 closed positions. Its largest new stake was GFL Environmental: 313,947 shares worth $10M. The largest sale was Sarepta Therapeutics, an estimated $27.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • TOBAM's largest Q2 2021 buy was GFL Environmental: 313,947 shares worth $10M.
  • TOBAM added most to Eli Lilly in Q2 2021, an estimated $23M increase.
  • TOBAM's biggest Q2 2021 reduction was Roku, cutting an estimated $20.6M.
  • TOBAM fully exited Sarepta Therapeutics in Q2 2021, selling an estimated $27.7M.
  • TOBAM's ten largest holdings make up 24% of its $2.5B portfolio in Q2 2021.
  • TOBAM opened 26 new positions and closed 20 in Q2 2021.
  • TOBAM's portfolio value rose 6.1% quarter-over-quarter to $2.5B.

Based on TOBAM's 13F filing for Q2 2021, filed 11 Aug 2021.